# Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

> **NCT07038837** · PHASE4 · RECRUITING · sponsor: **Epicentre** · enrollment: 70000 (estimated)

## Conditions studied

- Malaria Infection
- Malaria Vaccines

## Interventions

- **OTHER:** "Synchronised" arm (intervention)

## Key facts

- **NCT ID:** NCT07038837
- **Lead sponsor:** Epicentre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-16
- **Primary completion:** 2026-12
- **Final completion:** 2028-06
- **Target enrollment:** 70000 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038837, "Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07038837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*